This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new study data demonstrating that HeartBeam AI combined with vectorcardiography (VCG) outperformed an expert panel of heart rhythm cardiologists in detecting atrialflutter. for EP panel). for EP panel).
In the study, HeartBeam AI with VCG demonstrated a 28% improvement over single-lead ECG in the detection of atrialflutter cases (sensitivity of 91.0% for single-lead ECG) without sacrificing the ability to identify those individuals without atrialflutter (specificity of 98.7% for VCG vs. 71.2% for VCG vs. 96.9%
The representation of ECG vectors in X, Y, and Z axes in a vectorcardiogram (VCG) has shown diagnostic promise beyond single lead ECG (SL) analysis, with implications for novel ECG acquisition technologies. It is unclear how deep learning applied to VCG compares to physicians (EPs) for atrialflutter (AFL) detection.
ABSTRACT Atrialflutter (AFL), defined as macro-re-entrant atrial tachycardia, is associated with debilitating symptoms, stroke, heart failure, and increased mortality. Atypical AFL is a heterogenous group of re-entrant atrial tachycardias that most commonly occur in patients with prior heart surgery or catheter ablation.
The trial will evaluate the outcomes of therapy provided with the FARAPULSE PFA System versus AADs, including device-or procedure-related adverse events, the rates of freedom from AF, atrialflutter, or atrial tachycardia, as well as AF burden – a measurement of the amount of AF an individual experiences. Circulation.
In the written statement, he added, "A high bar has been set by performance of the system in clinical and commercial settings – where more than 40,000 patients have been treated to date – and we look forward to continuing to lead the way with this differentiated technology in the growing PFA space."
In a world where technology reigns supreme, one of the most profound tools in medicine remains the irreplaceable electrocardiogram (ECG). As technology advances, so too does our ability to capture the heart’s rhythm with greater precision. AFIB/AFL – atrial fibrillation or atrialflutter episodes.
AccurECG provides automated heart rate measurements, supraventricular and ventricular ectopic beat detection, and automated interpretation for 13 different arrhythmias such as atrial fibrillation, atrialflutter, and ventricular tachycardia.
2** Furthermore, the primary effectiveness endpoint (PEE) of acute pulmonary vein isolation and 12-month freedom from atrial arrhythmia recurrence (AF, Atrial Tachycardia, or AtrialFlutter) was 75.6%. iii] The study reported a low fluoroscopy time of 7.8 iii] The study reported a low fluoroscopy time of 7.8
With this approval, Medtronic now offers two PFA technologies available for patients with Afib. tim.hodson Wed, 10/30/2024 - 13:42 Oct. The Affera system was designed to address procedural challenges faced by the electrophysiology community while maintaining a high standard of safety and efficacy for patients.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content